JOHANNA MASEDA: Open Payments
NPI 1164778098 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 24 payments from 13 companies in 2025. Trend: 2023 $288 · 2024 $237 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 2 | $158 |
| Janssen Biotech, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 4 | $103 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| JAZZ PHARMACEUTICALS INC. | 2 | $64 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| PFIZER INC. | 3 | $45 |
| BeOne Medicines USA, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: MI CANCER SEEK, Enhertu, RYBREVANT, ZEPZELCA, Nubeqa, KEYTRUDA, TEVIMBRA, ALUNBRIG.
Industry payments across FL — which companies pay providers there.
